南宫NG·28(中国)相信品牌力量

Shanghai, China——On September 30, 2019, Shanghai Administration Bureau of Market Supervision and Shanghai Municipal Economic and Information Commission co-organized an exchanging meeting of the 2019 Shanghai key product quality research work experience, which announced the results of the 2019 Shanghai key product quality research projects and individuals. Industrialization upgrading project of Hercules™ Low Profile Thoracic Stent-Graft System was awarded the third prize of the 2019 Shanghai key product quality research achievement award for its technological innovation and industrial management advantages.

By encouraging enterprises to actively adopt new technologies, new processes, new equipment and new materials, the “Shanghai Key Product Quality Research Achievement Award” breaks through the key to quality improvement, basic technical problems and quality management problems, promoting the improvement of quality and technical level, quality management level and overall quality level. Thereby, Shanghai achieves energy conservation and consumption reduction, environmental protection, equipment renewal and safety production targets, effectively promotes industrial restructuring, optimization and upgrading, and enhances industrial competitiveness.

Hercules™ Low Profile Thoracic Stent-Graft System（“Hercules™ -LP Stent-Graft”）independently developed by Endovasctec™, which is upgrade product of Hercules™ Thoracic Stent-Graft System, mainly used for interventional treatment of thoracic aortic aneurys. It features a unique proximal tip-capture mechanism, which enables controlled deployment and accurate placement of the stent graft. At the same time, it reduced the diameter of the delivery sheath of the thoracic aortic stent graft to 18F for the first time. It is the thinnest of the similar products of the international thoracic aortic stent graft, which can benefit more patients. Through new technologies, new technologies and new materials, industrialization upgrading project of Hercules™ Low Profile Thoracic Stent-Graft System was selected, which carried out intelligent manufacturing and broke through the key points of quality improvement, achieving lower stent deployment force, lower permeability, higher outer sheath kink force and better positioning accuracy for largest stent. The continuous improvement in the quality of the Hercules™ -LP Stent-Graft allows doctors to work more easily, challenging more patients by challenging more complex cases.

The award of Endovasctec™ is an affirmation of the relevant departments of Shanghai to continuously optimize the production line process and ensure the quality of the products. It also reflects the company's ability to improve its technological innovation and product research. Endovasctec™ will adhere to the innovation-driven core competitiveness, lay a solid foundation, improve quality, and make more contributions to promoting the high-quality development of Shanghai's economy.